Abstract:Abstract Cerebral palsy is the most prevalent physical disability in children; however, its inherent molecular mechanisms remain unclear. In the present study, we performed in-depth clinical and molecular analysis on 120 idiopathic cerebral palsy families, and identified underlying detrimental genetic variants in 45% of these patients. In addition to germline variants, we found disease-related postzygotic mutations in ∼6.7% of cerebral palsy patients. We found that patients with more severe motor impairments or a comorbidity of intellectual disability had a significantly higher chance of harbouring disease-related variants. By a compilation of 114 known cerebral-palsy-related genes, we identified characteristic features in terms of inheritance and function, from which we proposed a dichotomous classification system according to the expression patterns of these genes and associated cognitive impairments. In two patients with both cerebral palsy and intellectual disability, we revealed that the defective TYW1, a tRNA hypermodification enzyme, caused primary microcephaly and problems in motion and cognition by hindering neuronal proliferation and migration. Furthermore, we developed an algorithm and demonstrated in mouse brains that this malfunctioning hypermodification specifically perturbed the translation of a subset of proteins involved in cell cycling. This finding provided a novel and interesting mechanism for congenital microcephaly. In another cerebral palsy patient with normal intelligence, we identified a mitochondrial enzyme GPAM, the hypomorphic form of which led to hypomyelination of the corticospinal tract in both human and mouse models. In addition, we confirmed that the aberrant Gpam in mice perturbed the lipid metabolism in astrocytes, resulting in suppressed astrocytic proliferation and a shortage of lipid contents supplied for oligodendrocytic myelination. Taken together, our findings elucidate novel aspects of the aetiology of cerebral palsy and provide insights for future therapeutic strategies.

Genetic Spectrum Identified by Exome Sequencing in a Chinese Pediatric Cerebral Palsy Cohort

Exome sequencing reveals genetic heterogeneity and clinically actionable findings in children with cerebral palsy

Exome sequencing in a Chinese cohort of children with cerebral palsy identifies likely pathogenic variants

Author Response for "genetic Spectrum and Clinical Profiles in a Southeast Chinese Cohort of Charcot‐Marie‐Tooth Disease"

Comprehensive whole-genome sequence analyses provide insights into the genomic architecture of cerebral palsy

Genetic Diagnosis Spectrum and Multigenic Burden of Exome-Level Rare Variants in a Childhood Epilepsy Cohort

Genetic investigations in cerebral palsy

Clinical utility of a genetic diagnosis in individuals with cerebral palsy and related motor disorders

The Genetic Puzzle of Cerebral Palsy: Results of a Monocentric Study

Exome-wide Association Study Identified Genetic Variants Contributing to the Risk of Cerebral Palsy

CNVbase: Batch Identification of Novel and Rare Copy Number Variations Based on Multi-Ethnic Population Data.

Clinical characteristics suggestive of a genetic cause in cerebral palsy: A systematic review

Genetic and Phenotype Analysis of a Chinese Cohort of Infants and Children With Epilepsy

Clinical and Genetic Spectrum of a Large Cohort of Children with Epilepsy in China

Identification of 11 Potentially Relevant Gene Mutations Involved in Growth Retardation, Intellectual Disability, Joint Contracture, and Hepatopathy

Mutations Disrupting Neuritogenesis Genes Confer Risk for Cerebral Palsy.

Clinical and Mutational Spectrum of Paediatric Charcot-Marie-Tooth Disease in a Large Cohort of Chinese Patients.

Clinical Targeted Panel Sequencing Analysis in Clinical Evaluation of Children with Autism Spectrum Disorder in China

The Genetic Spectrum of a Cohort of Patients Clinically Diagnosed As Parkinson's Disease in Mainland China.

Genetic Variants in the HLA Region Contribute to the Risk of Cerebral Palsy.

In-depth analysis reveals complex molecular aetiology in a cohort of idiopathic cerebral palsy